Robeauté Bets on Rice-Sized Microrobots for Brain Disease

Robeauté, a French neurotechnology startup, is developing rice-sized microrobots designed to enable precise delivery of drugs and therapies directly into areas of the brain that are difficult to access. The company's CEO stated that Robeauté plans for first-in-human studies in 2027, with a market launch targeted for the early 2030s.